Enfermedades Metabólicas y Neurodegeneración
Instituto Gulbenkian de Ciência
Oeiras, PortugalPublicaciones en colaboración con investigadores/as de Instituto Gulbenkian de Ciência (1)
2023
-
Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging
Journal of Neuroinflammation, Vol. 20, Núm. 1